glp-1 obesity drug news today sep 30 2025 september Nutritional priorities to support therapy for obesity: a joint Advisory GLP-1 drugs like Ozempic and

Amyloid- plaques can stimulate the NMDA-mediated influx of calcium ions (Zhou et al

Separating these possibilities without controlled studies remains impossible

These studies emphasize the significance of OXPHOS in CRC, the role of the reverse Warburg effect, and the metabolic heterogeneity within tumors, offering a comprehensive foundation for further investigation into the metabolic underpinnings of cancer progression and therapeutic resistance

Vitamin B12 monitoring is not routinely indicated for patients on GLP-1/GIP therapy alone but may be considered for those also taking metformin or with risk factors for deficiency